Has Mark Neault, MD received payments from drug or device companies?

Yes. Drug and device makers reported $18,019 in general payments to Mark Neault, MD across 74 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Neault, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Neault, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Neault, MD

Orthopaedic Surgery · Lincolnshire, ILNPI 1255329801

Payments from drug & device makers

$18,019in general payments, 2019–2025

Across 74 payments — averaging $243.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medacta USA, Inc.$12K
Arthrex$2K
Medwest Associates$2K
Lightbody Medical Technologies Inc$724
Zimmer Biomet$389
Johnson & Johnson$221
plus $123 from 4 others

What the payments were for

Travel & lodging$12,87171%
Food & beverage$2,74815%
Education$2,40013%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medacta USA, Inc.	22	$12,295
Arthrex	23	$2,394
Medwest Associates	5	$1,873
Lightbody Medical Technologies Inc	4	$724
Zimmer Biomet	6	$389
Johnson & Johnson	8	$221
Ferring Pharmaceuticals Inc.	2	$40
Orthofix Medical, Inc.	2	$35
Bioventus LLC	1	$34
Boston Scientific	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,019 in reported general payments places this provider in the 75th percentile of 844 orthopaedic surgery providers in Illinois.

See all orthopaedic surgery providers in Illinois →

Medicare billing

Part B allowed, 2024

$272,673

Medicare patients

489

Services billed

23,164

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Meloxicam	55	$154
Celecoxib	14	$153
Methylprednisolone	24	$116
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	12	$111
Tramadol Hcl	11	$27

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Lincolnshire

Peter BonuttiEffingham$24.3M
Steven HaddadGlenview$12.6M
Aaron RosenbergChicago$12.4M
Treg BrownHerrin$6.6M
Kamal IbrahimOakbrook Terrace$4.9M
Wayne GoldsteinMorton Grove$4.9M
Steven MatherDowners Grove$4.3M
Steven MardjetkoMorton Grove$4.3M
Steven ChudikWestmont$4.1M
Matthew SquireAurora$2.9M

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →